News & Events
Thought Leader Interview: Eric Topol
This is an extraordinary time in healthcare: we are witnessing nothing less than the democratization of medical information – about oneself, often generated by oneself – and the implications are industry-changing. – Dr. Eric Topol In an interview with University of Toronto’s Rotman Management Magazine, Dr. Eric Topol, Director of the Scripps Translational Science Institute,
Baseball innovator Paul DePodesta joins faculty at Scripps Translational Science Institute
Bringing Moneyball to medicine The Scripps Translational Science Institute (STSI) is delighted to announce that renowned baseball executive Paul DePodesta, whose work at the Oakland A’s helped inspire the book and subsequent movie “Moneyball”, will be joining their faculty. DePodesta, who will be joining STSI on a part time basis, helped revolutionize and “datafy” baseball
Time for a prepublication culture in clinical research?
Dr. Eric Topol urges clinical researchers to catch up with other scientific disciplines Within biology and clinical research, the communication of scientific results has followed the same formula for decades. Researchers and scientists submit their manuscripts to a journal, the journal then conducts a peer review, after which the manuscript is either rejected or accepted
Genome informatics company Cypher Genomics acquired by Human Longevity, Inc.
A new chapter for STSI’s first spin out Over the past decade, advances in DNA sequencing technologies have enabled researchers to quickly and relatively inexpensively generate large amounts of sequence data – data that could hold the keys to improving disease diagnosis and informing better treatment. The challenge however lies in deciphering all this information.
BioGPS – Building your own mashup of gene annotations and expression profiles
Free online tool by STSI researchers allows users to access a wide array of gene annotation resources Advances in next-generation sequencing and genomic screening technologies have led to an explosion in the amount of biomedical information that is currently available to researchers. Candidate gene lists can be generated faster than ever before and the portfolio
STSI launches home-based clinical research study using wearable sensors to detect asymptomatic atrial fibrillation
The mHealth Screening To Prevent Strokes trial seeks to identify and refine screening methods Researchers at the Scripps Translational Science Institute (STSI) have launched a home-based clinical trial that uses wearable sensor technology to identify people with asymptomatic atrial fibrillation (AFib). The primary objective of the mHealth Screening To Prevent Strokes (mSToPS) study is
New Addiction Research Challenge to Develop Mobile App using Apple’s ResearchKit™
STSI partners with National Institute on Drug Abuse to facilitate future research On November 3, 2015, the National Institute of Drug Abuse (NIDA) issued the “Addiction Research: There’s an App for That” Challenge. The Challenge calls on developers, data scientists and physicians to submit proposals for the development of mobile device applications designed to facilitate
Transforming Medicine mHealth conference – Summary interview with Dr. Steinhubl
The inaugural TRANSFORMING MEDICINE: Evidence-Driven mHealth conference hosted by the Scripps Translational Science Institute (STSI) took place in La Jolla, CA on October 1-2, 2015. With speakers from academia, industry, government, and health care, as well as from the seemingly unrelated fields of music and baseball, the conference sought to bring together people who are
Protective alleles and modifier variants in human health and disease
In a review article titled Protective alleles and modifier variants in human health and disease, Dr. Eric Topol, Director of the Scripps Translational Science Institute, discusses the impact of identifying genetic factors that protect individuals against disease, and the great potential this line of enquiry represents for the development of therapeutic agents. The article, written
Moving from Digitalization to Digitization in Cardiovascular Care
Why Is It Important, and What Could It Mean for Patients and Providers? “We are now at the cusp of the digital age of medicine – a time when pertinent data, previously locked away in a handwritten medical record or paper logbook, can be collected, aggregated, and analyzed at virtually the speed of light, and